Virulence Genotype and Phylogenetic Origin in Relation to Antibiotic Resistance Profile among Escherichia coli Urine Sample Isolates from Israeli Women with Acute Uncomplicated Cystitis
Open Access
- 1 January 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (1) , 26-31
- https://doi.org/10.1128/aac.49.1.26-31.2005
Abstract
To clarify the virulence and phylogenetic implications of antimicrobial agent resistance in Escherichia coli , 100 E. coli isolates from urine samples of Israeli women with acute uncomplicated cystitis were analyzed by molecular phylotyping and virulence genotyping for comparison with resistance phenotypes. The differences between the isolates that were resistant and susceptible to trimethoprim-sulfamethoxazole and ampicillin were minimal. In contrast, ciprofloxacin resistance was associated with greatly reduced inferred virulence and categorical shifts away from the highly virulent phylogenetic group B2, which explained much of the virulence effect. The results of amplification fingerprinting suggested that most ciprofloxacin-resistant isolates represented unique clonal groups and were not derived from clonal groups with more highly virulent susceptible isolates. These findings suggest that virulence and antimicrobial resistance are not mutually exclusive in E. coli clinical isolates. Instead, the relationship between virulence and antimicrobial resistance varies according to the particular resistance phenotype; for ciprofloxacin resistance, the relationship is strongly influenced by phylogenetic background. The basis for the concentration of ciprofloxacin resistance in non-B2 phylogenetic groups remains unknown.Keywords
This publication has 44 references indexed in Scilit:
- Global Molecular Epidemiology of the O15:K52:H1 Extraintestinal Pathogenic Escherichia coli Clonal Group: Evidence of Distribution beyond EuropeJournal of Clinical Microbiology, 2002
- Empiric Use of Trimethoprim‐Sulfamethoxazole (TMP‐SMX) in the Treatment of Women with Uncomplicated Urinary Tract Infections, in a Geographical Area with a High Prevalence of TMP‐SMX–Resistant UropathogensClinical Infectious Diseases, 2002
- Decreased Invasive Capacity of Quinolone‐ResistantEscherichia coliin Patients with Urinary Tract InfectionsClinical Infectious Diseases, 2001
- Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-ResistantEscherichia coliClonal GroupNew England Journal of Medicine, 2001
- Antimicrobial Resistance Among Uropathogens that Cause Community‐Acquired Urinary Tract Infections in Women: A Nationwide AnalysisClinical Infectious Diseases, 2001
- Urinary Tract InfectionAnnals of Epidemiology, 2000
- The ECOSENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim reportJournal of Antimicrobial Chemotherapy, 2000
- Extended Virulence Genotypes ofEscherichia coliStrains from Patients with Urosepsis in Relation to Phylogeny and Host CompromiseThe Journal of Infectious Diseases, 2000
- Diagnosis of Coliform Infection in Acutely Dysuric WomenNew England Journal of Medicine, 1982
- The Colonization of the Human Gut by Antibiotic Resistant Escherichia coli from ChickensJournal of Applied Bacteriology, 1977